视网膜厚度变异性对新血管性年龄相关性黄斑变性视觉结局和积液持续的影响:HAWK与HARRIER研究的事后分析
该事后分析纳入1752例接受抗血管内皮生长因子治疗的新血管性年龄相关性黄斑变性患眼,按中央亚区厚度变异四分位分组,评估其与最佳矫正视力及视网膜积液的关系。结果显示,中央亚区厚度变异性越大,研究终点的最佳矫正视力越差,最高与最低变异四分位组间最小二乘均值差为8.9个ETDRS字母;变异性增大还与积液就诊比例升高相关。
要点
- 中央亚区厚度变异性越大,研究终点最佳矫正视力越差,最高与最低变异四分位组间差8.9个ETDRS字母。
- 中央亚区厚度变异性增大与积液就诊平均比例升高相关。
- 更稳定的中央亚区厚度与治疗终点更好的视觉结局相关,提示其可能比单纯积液存在更可靠的预后标志。
核心结论
- 更稳定的中央亚区厚度与治疗终点更好的视觉结局相关,提示中央亚区厚度变异性可能比单纯积液存在提供更可靠的视觉结局预后标志,并可能改善新血管性年龄相关性黄斑变性患者的临床照护。
研究设计与样本
- HAWK与HARRIER研究的事后、治疗无关分析,纳入1752例患者,按中央亚区厚度变异递增四分位分组。
- 采用重复测量多水平模型,评估从基线或负荷期结束至研究终点中央亚区厚度变异性与最佳矫正视力的关联,并评估其与视网膜积液存在的关联。
主要发现
- 中央亚区厚度变异性增大与研究终点更差的最佳矫正视力结局相关,末次访视时最低与最高变异四分位组间最佳矫正视力最小二乘均值差为8.9个早期治疗糖尿病视网膜病变研究字母。
- 中央亚区厚度变异性增大还与积液存在的就诊平均比例升高相关。
关键数值与推荐
- 中央亚区厚度变异最高与最低四分位组间末次访视最佳矫正视力最小二乘均值差为8.9个早期治疗糖尿病视网膜病变研究字母。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To determine the association between central subfield thickness (CST) variability and visual outcomes in eyes with neovascular age-related macular degeneration treated with anti-vascular endothelial growth factor therapies. METHODS: In this post hoc, treatment-agnostic analysis, patients (N = 1,752) were grouped into quartiles of increasing CST variation. The association between CST variability and best-corrected visual acuity was measured from baseline, or from the end of the loading phase, until the end of the study using a multilevel modeling for repeated-measures model. The association between CST variability and the presence of retinal fluid was also assessed. RESULTS: Increased CST variability was associated with worse best-corrected visual acuity outcomes at the end of study, with a least-square mean difference in best-corrected visual acuity of 8.9 Early Treatment Diabetic Retinopathy Study letters between the quartiles with the lowest and highest CST variability at the final visit. Increased variability was also associated with a higher mean fraction of visits with the presence of fluid. CONCLUSION: More stable CST was associated with better visual outcomes at the end of treatment suggesting that CST variability may provide a more reliable prognostic marker of visual outcomes than the presence of fluid alone, with the potential to enhance the clinical care of neovascular age-related macular degeneration patients.
引用
- Dugel PU, Jhaveri CD, Chakravarthy U, et al. EFFECT OF RETINAL THICKNESS VARIABILITY ON VISUAL OUTCOMES AND FLUID PERSISTENCE IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: A Post Hoc Analysis of the HAWK and HARRIER Studies. Retina. 2022. PMID: 34923515. doi:10.1097/IAE.0000000000003349
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。